kevin-johnson.bsky.social
Research Scientist in Department of Neurosurgery Yale University studying glioma evolution
👤 Joined on 18 November 2024
Followers
Following
Total Posts
@kevin-johnson.bsky.socialGlioblastoma is monitored mostly by MRI, which can miss early changes. Cell-free DNA (cfDNA) in blood is a promising alternative, but we know little about what governs its release. Our new paper in Neuro-Oncology, led by @sharvarimankame.bsky.social, dissects it. 🧵 doi.org/10.1093/neuonc/noag204
Show PostTogether: cfDNA composition depends on tumor proliferation, the microenvironment and treatment. Interpreting a liquid biopsy in GBM will require accounting for that context. Next up: testing these principles in patient samples. Stay tuned.
Show PostNew data from Dr. Erica Shen #ASTRO2026 finds in adults undergoing allogeneic stem cell transplant for ALL or AML, TBI with lung shielding yielded a 13.4% rate of severe pulmonary toxicity. @astro-org.bsky.social @oncoalert.bsky.social
Show PostI propose Super Terrific Ultra Platinium Intelligence... Deluxe!
Show PostWent on live TV news last night talking about AI safety and #biosecurity
Show Post